DAHANCA

From Wikipedia, the free encyclopedia

DAHANCA refers to the "Danish Head and Neck Cancer Study". It actually refers to a series of studies, the most recent of which is "DAHANCA 10". Other notable studies include DAHANCA 5[1] and DAHANCA 6/7.[2]

It operates under the authority of the Danish Society for Head and Neck Oncology.

[edit] See also

[edit] References

  1. ^ Eriksen JG, Overgaard J (2007). "Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: An evaluation of the DAHANCA 5 study>". doi:10.1016/j.radonc.2007.05.009. PMID 17543403. 
  2. ^ Overgaard J, Hansen HS, Specht L, et al (2003). "Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial". Lancet 362 (9388): 933–40. PMID 14511925. 

[edit] External links

 This oncology article is a stub. You can help Wikipedia by expanding it.